NCT06136793

Brief Summary

Individuals of Chinese heritage are the largest and fastest growing segment of the US Asian population. US Chinese have sociodemographic characteristics and culture that differ substantially from other US Asians, and therefore, differ in social determinants of health, health status, and disease risk. US Chinese adults are at increased risk for cardiometabolic disease, related conditions (obesity, type 2 diabetes mellitus, hypertension), and systemic inflammation that promotes disease onset and progression. Immigration to a new country can substantially impact the gut microbiome which may promote systemic inflammation. Pilot interventions indicate a high-fiber diet rich in whole grains reduced inflammation and improved obesity. Additionally, the United States Department of Agriculture (USDA) supported, evidence-based HomeStyles intervention has demonstrated feasibility, acceptability, and efficacy in improving lifestyle behaviors and home environments associated with obesity risk in families. A lack of linguistically, culturally tailored interventions to their specific health needs makes it difficult for US Chinese to implement healthy lifestyle behaviors and reduce health risks. Interventions tailored for US Chinese that could attenuate modifiable cardiometabolic risk factors, understand physiological sequelae, and bridge health equity are not currently available. Thus, the overall goal of this project is to test the efficacy of HomeStyles in improving health outcomes in US Chinese. Project aims are to: A) Culturally adapt the HomeStyles intervention through community-engaged approaches. B) Conduct a 10-week, 2-armed Randomized Controlled Trial (RCT) to test HomeStyles intervention efficacy on health outcomes (dietary intake, physical activity, self-efficacy, HbA1C, waist circumference, and BMI), hypothesizing that participants randomized to the treatment condition will have greater improvements in health outcomes than control comparators. C) Examine associations between intervention participation and gut microbiota/systemic inflammation and test hypotheses that a whole-grain rich diet adopted by those in the intervention group will increase anti-inflammatory gut bacteria, reduce inflammatory gut bacteria, and lower systemic inflammation.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Aug 2024Aug 2027

First Submitted

Initial submission to the registry

November 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

August 25, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

2.7 years

First QC Date

November 8, 2023

Last Update Submit

March 20, 2026

Conditions

Keywords

Chinese heritageAsianCardiometabolic diseaseChinaChineseChronic diseaseHealth behaviorDietary intakephysical activityhome environmentinflammationrandomized control trialbody mass indexhypertensiondiabetes mellitushealth disparitiesfamilysleepself efficacy

Outcome Measures

Primary Outcomes (8)

  • Participant Health-related behaviors: Fruit/Vegetable/Fiber Intake (servings/day)

    Dietary intake: Block Fruit/Vegetable/Fiber Screener servings/day; possible range 0 to infinity

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Health-related behaviors: Sugar-sweetened Beverage Intake (servings/day)

    Dietary intake: HOMES Sugar-sweetened beverage Intake servings/day; possible range 0 to infinity

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Health-related behaviors: Physical Activity Level

    Physical activity: Streamlined International Physical Activity Questionnaire; possible range 0 to 49; 49 is highest

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Health-related behaviors: Self-Efficacy for Health Behaviors

    HOMES Self-Efficacy for Engaging in Healthy Cardiometabolic Behaviors; possible score range 1 to 5; 5 is highest

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Cardiometabolic Disease Markers: Diabetes Risk

    HbA1c; percentage; normal below 5.7%; prediabetes 5.7 to 6.4%; diabetes 6.5% or above

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Cardiometabolic Disease Markers: Height (for BMI calculation)

    Height (in cm)

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Cardiometabolic Disease Markers: Weight (for BMI calculation)

    Weight (in kg)

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Cardiometabolic Disease Markers: Waist circumference

    Waist circumference (in cm) for central adiposity assessment

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

Secondary Outcomes (15)

  • Participant Health-related Behavior: Sleep duration

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Cardiometabolic Disease Marker: Lipid

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Participant Cardiometabolic Disease Marker: Inflammation

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Fruit/Vegetable/Fiber Intake (servings/day)

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • Other adult living in household with a cardiometabolic condition, if participant does not have cardiometabolic condition: Sugar-Sweetened Beverage Intake (servings/day)

    Pre-intervention (baseline), post-intervention (~10 weeks after baseline), follow-up (~12 weeks after post-intervention)

  • +10 more secondary outcomes

Study Arms (2)

Experimental: Healthy HomeStyles

EXPERIMENTAL

Online educational intervention

Behavioral: HomeStyles-China

Active Comparator: Safe HomeStyles

ACTIVE COMPARATOR

Online educational intervention

Behavioral: HomeStyles-China

Interventions

2-arm \~10 week educational intervention

Active Comparator: Safe HomeStylesExperimental: Healthy HomeStyles

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult of Chinese heritage \>30 years with a self-reported cardiometabolic condition or living with an adult (spouse/partner, parent) with a cardiometabolic condition; primary food gatekeeper in the household (i.e., makes all or most decisions related to family food choices); has regular Internet access, read English and/or Chinese, and resides in New York/New Jersey metro area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers University

New Brunswick, New Jersey, 08901, United States

Location

MeSH Terms

Conditions

Health BehaviorFeeding BehaviorSedentary BehaviorDiabetes MellitusChronic DiseaseMotor ActivityInflammationHypertension

Condition Hierarchy (Ancestors)

BehaviorBehavior, AnimalGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular Diseases

Study Officials

  • Carol Byrd-Bredbenner

    Rutgers University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
concurrent treatments different in subject matter but equal in nonspecific treatment effects
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: RCT
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Distinguished Professor of Nutrition

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 18, 2023

Study Start

August 25, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Deidentified primary and secondary outcome data will be shared after study data are published and upon request

Shared Documents
STUDY PROTOCOL
Time Frame
At the conclusion of the study after study data are published
Access Criteria
Request for data access to PI

Locations